Alto Neuroscience (ANRO) Interest Expenses (2023 - 2026)
Alto Neuroscience (ANRO) reported Interest Expenses of $545000.0 for Q1 2026, down 72.75% on a YoY basis from $2.0 million in Q1 2025, and up 28.24% sequentially from $425000.0 in Q4 2025.
Alto Neuroscience (ANRO) Interest Expenses (2023 - 2026) Analysis & Trends
Alto Neuroscience (ANRO) has 4 years of Interest Expenses data on file, last reported at $545000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses fell 72.75% year-over-year to $545000.0; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (down 17.4% YoY), and the FY2025 full-year result was $52.1 million, up 39.42% from the prior year.
- Interest Expenses climbed to $545000.0 in Q1 2026, from $425000.0 in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $1.8 billion in Q3 2025 to a low of -$102000.0 in Q4 2023.
- A 4-year average of $169.8 million and a median of $400000.0 in 2023 frame the typical range for Interest Expenses.
- Across the five-year window, Interest Expenses jumped 527120.63% in 2025 and plunged 72.75% in 2026, its largest moves.
- Tracing ANRO's Interest Expenses over 4 years: stood at -$102000.0 in 2023, then surged by 426.47% to $333000.0 in 2024, then climbed by 27.63% to $425000.0 in 2025, then increased by 28.24% to $545000.0 in 2026.
- Business Quant data shows ANRO's Interest Expenses at $545000.0 in Q1 2026, $425000.0 in Q4 2025, and $1.8 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Alto Neuroscience | 869.36 Mn | 869.36 Mn | - | 545,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 545,000.00 |
| Mar 31, 2026 | 545,000.00 |
| Dec 31, 2025 | 425,000.00 |
| Dec 31, 2025 | 425,000.00 |
| Sep 30, 2025 | 1.84 Bn |
| Sep 30, 2025 | 1.84 Bn |
| Jun 30, 2025 | 362.00 Mn |
| Jun 30, 2025 | 362.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Mar 31, 2025 | 2.00 Mn |
| Dec 31, 2024 | 333,000.00 |
| Dec 31, 2024 | 333,000.00 |
| Sep 30, 2024 | 349,000.00 |
| Sep 30, 2024 | 349,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Jun 30, 2024 | 400,000.00 |
| Mar 31, 2024 | 346,000.00 |
| Mar 31, 2024 | 346,000.00 |
| Dec 31, 2023 | -102,000.00 |
| Dec 31, 2023 | -102,000.00 |